Skip to content

Homoeopathic Treatment of Upper Respiratory Tract Infection in Children

Individualized Homoeopathic Medicines in the Treatment of Upper Respiratory Tract Infections in Children Using Kentâ??s Repertory: A Double-blind, Randomized, Placebo controlled Clinical Trial

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2020/12/029683
Enrollment
60
Registered
2020-12-09
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J00-J06- Acute upper respiratory infections

Interventions

Sponsors

Mahesh Bhattacharyya Homoeopathic Medical College and Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Willingness and consent of the parents or immediate caregivers for inclusion in this study 2. Clinical signs and symptoms of a URTI with a duration of up to 24hours accompanied with or without fever >=37.5áµ?C (axillary body temperature) 3. At least 1 of 3 types of URTI symptoms â?? Nasal (plugged nose, runny nose, sneezing), Pharyngeal (scratchy throat, sore throat, pharyngeal hyperaemia), Cough (ordinary cough without suspicion of acute lower respiratory tract disease). 4. At least 1 of 5 general symptoms â?? feeling tired, weakness, body ache, irritable or whiney, or less active

Exclusion criteria

Exclusion criteria: 1. Severe or complicated course of URTI. 2. Persistent fever more than 1020F 3. Signs of acute lower respiratory tract disease. 4. Current symptoms mainly induced by other acute ENT diseases. 5. Daily use of antibiotics, steroids and cytotoxic agents. 6. Children on active treatment from any other system of medicine. 7. Children with any uncontrolled systemic disease, infection, and any organ failure. 8. Severe co morbidity including previous malignant disease during the past 5year prior enrolment.

Design outcomes

Primary

MeasureTime frame
Canadian Acute Respiratory Illness and Flu Scale (CARIFS-18)Timepoint: Baseline, 3 days, 7 days, 14 days

Secondary

MeasureTime frame
Adverse events (persistent fever, additional medication, spread of infections etc.)Timepoint: Event record;Symptom Score for RTITimepoint: Baseline, 3 days, 7 days, 14 days;Time taken for complete resolution of symptomsTimepoint: Counted in days

Countries

India

Contacts

Public ContactShubhamoy Ghosh

Mahesh Bhattacharyya Homoeopathic Medical College &Hospital

shubhamoy67@gmail.com9831034229

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026